Skip to main content
. 2018 Jan 12;20(2):218–225. doi: 10.1016/j.neo.2017.12.002

Figure 3.

Figure 3

Example of PDL1 expression increasing after targeted therapy.

(A) Histology of HE and PDL1 staining at 4× magnification of a patient before and after combination BRAF and MEK inhibitor treatment. PDL1 staining was evaluated in the tumor cells.

(B) Histology of HE and PDL1 staining at 10× magnification of a patient before and after combination BRAF and MEK inhibitor treatment. PDL1 staining was evaluated in the tumor cells.